Serum YKL-40 as a biomarker for predicting loss of lung function and neutrophilic airway inflammation in asthma, COPD and asthma-COPD overlap - Milan 2023

Genetic and biological mechanisms in chronic airway disease

Chair(s): Ian M. Adcock, Anita Somborac Bacura

Session type: Oral presentation

Serum YKL-40 as a biomarker for predicting loss of lung function and neutrophilic airway inflammation in asthma, COPD and asthma-COPD overlap

Yasuhito Suzuki

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Dysanapsis Genetic Risk and Chronic Obstructive Pulmonary Disease Mortality

Leina Kingdom

Replay

Abstract

Slides

Genetic screening for cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) in patients with chronic cough. Preliminary analysis

Esther Palones

Replay

Poster

Abstract

Slides

Breath metabolomics to monitor the response to CFTR modulators in adults with cystic fibrosis

Emmanuelle Bardin

Replay

Poster

Abstract

Slides

Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival but is decoupled from FEV1 decline

Daniel Fraughen

Replay

Poster

Abstract

Slides

Patients with chronic airway disease: Insights from a sputum proteome analysis

Stefanie Graeter

Replay

Poster

Abstract

Slides

Serum YKL-40 as a biomarker for predicting loss of lung function and neutrophilic airway inflammation in asthma, COPD and asthma-COPD overlap

Yasuhito Suzuki

Replay

Poster

Abstract

Slides

Airway extracellular copper concentrations increase with age and are associated with oxidative stress independent of disease state.

Andreas Frolich

Replay

Poster

Abstract

Slides

A novel mice model investigating the effect of low-dose PM2.5 exposure on lung health

Min Feng

Replay

Poster

Abstract

Slides

Ciliary dyskinesia is not affected by chronic mucus hypersecretion in severe asthma

Celine Kempeneers

Replay

Poster

Abstract

Slides

Effect of Mepolizumab on airways remodeling in patients with late-onset severe eosinophilic asthma and fixed obstruction (preliminary data of the MESILICO study)

Kalliopi Domvri

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}